Accéder au contenu
Merck
  • Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea.

Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea.

The Journal of clinical endocrinology and metabolism (2014-05-16)
Rahul Yadav, Michael France, Reza Aghamohammadzadeh, Yifen Liu, Salam Hama, See Kwok, Jonathan Schofield, Peter Turkington, Akheel A Syed, Rayaz Malik, Philip Pemberton, Adam Greenstein, Paul Durrington, Basil Ammori, Martin Gibson, Maria Jeziorska, Handrean Soran
RÉSUMÉ

Obstructive sleep apnea (OSA) complicates morbid obesity and is associated with increased cardiovascular disease incidence. An increase in the circulating markers of chronic inflammation and dysfunctional high-density lipoprotein (HDL) occur in severe obesity. The objective of the study was to establish whether the effects of obesity on inflammation and HDL dysfunction are more marked when complicated by OSA. Morbidly obese patients (n = 41) were divided into those whose apnea-hypoapnea index (AHI) was more or less than the median value and on the presence of OSA [OSA and no OSA (nOSA) groups]. We studied the antioxidant function of HDL and measured serum paraoxonase 1 (PON1) activity, TNFα, and intercellular adhesion molecule 1 (ICAM-1) levels in these patients. In a subset of 19 patients, we immunostained gluteal sc adipose tissue (SAT) for TNFα, macrophages, and measured adipocyte size. HDL lipid peroxide levels were higher and serum PON1 activity was lower in the high AHI group vs the low AHI group (P < .05 and P < .0001, respectively) and in the OSA group vs the nOSA group (P = .005 and P < .05, respectively). Serum TNFα and ICAM-1 levels and TNFα immunostaining in SAT increased with the severity of OSA. Serum PON1 activity was inversely correlated with AHI (r = -0.41, P < .03) in the OSA group. TNFα expression in SAT directly correlated with AHI (r = 0.53, P < .03) in the subset of 19 patients from whom a biopsy was obtained. Increased serum TNFα, ICAM-1, and TNFα expression in SAT provide a mechanistic basis for enhanced inflammation in patients with OSA. Decreased serum PON1 activity, impaired HDL antioxidant function, and increased adipose tissue inflammation in these patients could be a mechanism for HDL and endothelial dysfunction.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cholestérol, Sigma Grade, ≥99%
Sigma-Aldrich
Phénol solution, BioReagent, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, for molecular biology
Sigma-Aldrich
Cholestérol, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
Cholestérol, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
Phénol solution, BioReagent, Saturated with 0.01 M citrate buffer, pH 4.3 ± 0.2, for molecular biology
Sigma-Aldrich
Phénol, ≥99%
Sigma-Aldrich
Phénol, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
Sigma-Aldrich
SyntheChol® NS0 Supplement, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
SAFC
Cholestérol, SyntheChol®
Supelco
Cholesterol solution, certified reference material, 10 mg/mL in chloroform
Sigma-Aldrich
Phénol, natural, 97%, FG
Sigma-Aldrich
Phénol solution, ≥89.0%
USP
Phénol, United States Pharmacopeia (USP) Reference Standard
Supelco
Phénol solution, certified reference material, 500 μg/mL in methanol
Sigma-Aldrich
Phénol, BioUltra, for molecular biology, TE-saturated, ~73% (T)
Sigma-Aldrich
Phénol, for molecular biology
Supelco
Cholestérol, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Phénol solution, 5000 μg/mL in methanol, certified reference material
Supelco
Phénol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Phénol, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
Cholestérol, from lanolin, ≥99.0% (GC)
Sigma-Aldrich
Phénol, puriss., ≥99.5% (GC), meets analytical specification of Ph. Eur., BP, USP, crystalline (detached)
Sigma-Aldrich
Phénol, contains hypophosphorous as stabilizer, loose crystals, ACS reagent, ≥99.0%
Sigma-Aldrich
Phénol, unstabilized, ReagentPlus®, ≥99%
Supelco
Phénol, PESTANAL®, analytical standard
Sigma-Aldrich
Phénol, ≥96.0% (calc. on dry substance, T)
SAFC
Cholestérol, from sheep wool, Controlled origin, meets USP/NF testing specifications
Sigma-Aldrich
Cholestérol, tested according to Ph. Eur.
Sigma-Aldrich
Phénol, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC)
Sigma-Aldrich
Phénol, unstabilized, purified by redistillation, ≥99%